Lewis T Williams's Net Worth
$156 Million
Who is Lewis T Williams?
Lewis T Williams has an estimated net worth of $156 Million. This is based on reported shares across multiple companies, which include Arcellx, Inc., Protagonist Therapeutics, Inc, Neoleukin Therapeutics, Inc., BECKMAN COULTER INC, and FIVE PRIME THERAPEUTICS, INC..
SEC CIK
Lewis T Williams's CIK is 0001475714
Past Insider Trading and Trends
2016 was Lewis T Williams's most active year for acquiring shares with 19 total transactions. Lewis T Williams's most active month to acquire stocks was the month of January. 2016 was Lewis T Williams's most active year for disposing of shares, totalling 40 transactions. Lewis T Williams's most active month to dispose stocks was the month of January. 2018 saw Lewis T Williams paying a total of $415,949.52 for 138,217 shares, this is the most they've acquired in one year. In 2016 Lewis T Williams cashed out on 693,154 shares for a total of $13,273,210.83, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Arcellx, Inc. (ACLX) Snapshot price: $66.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.1M |
—
|
—
| 2.1M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Protagonist Therapeutics, Inc (PTGX) Snapshot price: $25.76
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neoleukin Therapeutics, Inc. (NLTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BECKMAN COULTER INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.37K |
$83.50 | -$114,228.00 |
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 13
| |||
Form 4
| +73.18% | 580 |
—
|
—
| 1.37K |
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
| +462.86% | 648 |
—
|
—
| 788 |
Jan 7
| |||
Form 4
|
∞
| 140 |
—
|
—
| 140 |
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FIVE PRIME THERAPEUTICS, INC. No price found
Executive Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.52% | -7.02K |
$5.43 | -$38,140.32 | 455.34K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4/A
| +0.22% | 1K |
—
|
—
| 462.36K |
Feb 25
| |||
Form 4
| -0.20% | -926.00 |
$11.95 | -$11,065.70 | 461.36K |
Feb 26
| |||
Form 4
| -0.68% | -3.14K |
$11.43 | -$35,935.92 | 462.29K |
Feb 5
| |||
Form 4
| +24.38% | 91.22K |
$4.56 | $415,949.52 | 465.43K |
Nov 5
| |||
Form 4
| -1.84% | -7.02K |
$14.00 | -$98,336.00 | 374.21K |
Sep 1
| |||
Form 4
| +1.33% | 5K |
—
|
—
| 381.24K |
Feb 26
| |||
Form 4/A
|
—
|
0
|
—
|
—
| 428.83K |
Sep 1
| |||
Form 4/A
| -11.85% | -55.03K |
$44.74 | -$1,459,105.62 | 409.3K |
Sep 1
| |||
Form 4
| -0.83% | -3.14K |
$18.42 | -$57,783.54 | 376.24K |
Feb 5
| |||
Form 4
| -2.01% | -7.83K |
$34.34 | -$268,779.18 | 381.96K |
Sep 1
| |||
Form 4
| -8.16% | -34.53K |
$44.77 | -$1,545,997.64 | 388.75K |
Mar 1
| |||
Form 4
| -1.29% | -5.54K |
—
|
—
| 423.29K |
Sep 1 - Feb 7
| |||
Form 4
| -1.17% | -5.07K |
$48.60 | -$246,159.00 | 428.83K |
Jan 3
| |||
Form 4
|
—
|
0
|
$28.02 | -$1,348,755.75 | 433.89K |
Scheduled
|
Dec 23
| ||
Form 4
| -0.09% | -407.00 |
—
|
—
| 433.89K |
Sep 14
| |||
Form 4
| -6.47% | -30.03K |
$44.74 | -$1,343,497.46 | 434.3K |
Sep 1
| |||
Form 4
| +10.08% | 42.5K |
—
|
—
| 464.33K |
Aug 25
| |||
Form 4
| +23.87% | 81.3K |
$1.23 | $99,999.00 | 421.83K |
May 6
| |||
Form 4
|
—
|
0
|
$28.27 | -$1,925,397.26 | 340.53K |
Scheduled
|
Apr 20 - Apr 21
| ||
Form 4
|
—
|
0
|
$28.25 | -$55,511.55 | 340.53K |
Scheduled
|
Apr 15
| ||
Form 4
|
—
|
0
|
$28.25 | -$107,664.75 | 340.53K |
Scheduled
|
Apr 14
| ||
Form 4
|
—
|
0
|
$25.79 | -$1,826,727.35 | 340.53K |
Scheduled
|
Apr 5 - Apr 6
| ||
Form 4
|
—
|
0
|
$23.46 | -$770,478.52 | 340.53K |
Scheduled
|
Mar 29 - Mar 30
| ||
Form 4
|
—
|
0
|
$21.45 | -$677,302.08 | 340.35K |
Scheduled
|
Mar 2
| ||
Form 4
|
—
|
0
|
$18.96 | -$2,050,793.00 | 340.35K |
Scheduled
|
Feb 4
| ||
Form 4
| -0.28% | -953.00 |
—
|
—
| 340.3K |
Dec 24
| |||
Form 4
| +17.17% | 50K |
—
|
—
| 341.26K |
Nov 16
| |||
Form 4
| -1.13% | -3.34K |
—
|
—
| 291.26K |
Oct 22
| |||
Form 4
| -19.72% | -72.35K |
$27.24 | -$1,970,508.64 | 294.59K |
Scheduled
|
Oct 15
| ||
Form 4
| -0.72% | -2.65K |
$22.06 | -$58,422.29 | 366.94K |
Scheduled
|
Sep 21
| ||
Form 4
| +25.46% | 75K |
—
|
—
| 369.59K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
| -20.29% | -75.00K |
$24.67 | -$1,850,379.70 | 294.59K |
Scheduled
|
Jun 22
| ||
Form 4
| +3.67% | 13.09K |
—
|
—
| 369.59K |
Apr 30
| |||
Form 4
| -8.38% | -32.60K |
$13.08 | -$426,409.01 | 356.5K |
Scheduled
|
Oct 31 - Nov 4
| ||
Form 4
| -4.28% | -17.40K |
$13.13 | -$228,473.41 | 389.11K |
Scheduled
|
Oct 28 - Oct 30
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||